| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 104.94M | 102.09M | 103.16M | 59.78M | 56.48M |
| Gross Profit | 99.33M | 102.09M | 102.19M | 59.29M | 46.77M |
| EBITDA | 80.87M | -5.00K | 59.74M | 41.59M | 30.32M |
| Net Income | 56.57M | 49.60M | 40.41M | 26.36M | 30.32M |
Balance Sheet | |||||
| Total Assets | 851.54M | 812.34M | 823.68M | 868.83M | 634.27M |
| Cash, Cash Equivalents and Short-Term Investments | 11.90M | 11.20M | 19.75M | 23.30M | 12.95M |
| Total Debt | 203.52M | 193.40M | 214.92M | 268.90M | 267.66M |
| Total Liabilities | 254.53M | 232.98M | 237.85M | 291.29M | 274.92M |
| Stockholders Equity | 597.01M | 579.36M | 585.83M | 577.54M | 359.34M |
Cash Flow | |||||
| Free Cash Flow | 45.23M | 84.41M | 102.69M | 68.14M | 7.57M |
| Operating Cash Flow | 45.80M | 84.57M | 102.82M | 68.41M | 7.57M |
| Investing Cash Flow | -14.79M | -156.00K | -137.00K | -9.84M | -21.58M |
| Financing Cash Flow | -30.30M | -92.96M | -106.24M | -48.22M | -35.58M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | £605.13M | 5.68 | 30.00% | 8.73% | 7.71% | -7.39% | |
76 Outperform | £8.97B | 11.95 | 12.35% | 5.37% | 4.78% | -4.86% | |
73 Outperform | £431.30M | 7.48 | 44.99% | 5.73% | ― | ― | |
71 Outperform | £498.52M | 10.05 | 9.58% | 5.79% | 82.69% | 21.07% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | £4.68B | 5.37 | 23.35% | 4.13% | 28.34% | 44.04% | |
52 Neutral | £6.93B | 22.80 | 9.49% | 7.09% | 9.86% | -134.41% |